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INTRODUCTION:  Myasthenia  gravis  (MG) has been  reported  to correlate  with  earlier-stage  thymoma,  and
theoretically  does  not  accompany  thymic  carcinoma.  However,  we encountered  two  cases  of  thymic
carcinoma  with MG.
PRESENTATION OF CASES:  Case  1 involved  a  54-year-old  man  who  had  been  diagnosed  with MG based
on  symptoms  and detection  of anti-acetylcholine  receptor  antibody  (ARAB).  Computed  tomography  (CT)
revealed  an  anterior  mediastinal  tumor  30 mm  in  diameter.  Prednisolone  (PSL)  and  tacrolimus  were
administered  without  surgery  at  that  time.  Six years  after  diagnosis  of  MG,  he was  admitted  to  our
hospital  and  underwent  extended  thymectomy.  Pathological  examination  revealed  type  B2-B3  thymoma
according  to World  Health  Organization  criteria,  comprising  80%  of the tumor  with  small  cell  carcinoma
as  20%.  Case  2 involved  a 51-year-old  woman.  She  had  been  diagnosed  with  MG  based on eyelid  ptosis
and  detection  of ARAB.  Ten  years  after  diagnosis  of  MG, diaphragm  elevation  was  detected  on  chest  X-ray.
CT revealed  an  anterior  mediastinal  tumor,  47  mm  in  diameter.  We  suspected  tumor  invasion  to the  right
phrenic  nerve,  right  atrium, and  superior  vena  cava.  We  therefore  performed  extended  thymectomy  after
preoperative  radiotherapy  (40 Gy).  Pathological  examination  revealed  squamous  cell  carcinoma.
DISCUSSION:  Most  cases  of  thymic  carcinomas  appear  to  arise  de  novo,  but  appearance  in thymomas
has  been  described.  In both  our cases,  MG  was  treated  with  pharmacotherapy  alone  without  extended
thymectomy,  and  thymic  carcinoma  was  considered  to  have  developed  from  the thymoma  during  long-
term follow-up.
CONCLUSION:  Thymic  carcinoma  can  accompany  MG.
© 2016  The  Authors.  Published  by Elsevier  Ltd  on  behalf  of IJS  Publishing  Group  Ltd.  This  is an  open
he CCaccess  article  under  t
. Introduction
Thymomas are neoplasms arising from or exhibiting differenti-
tion toward thymic epithelial cells, into which immature T cells
re mixed in various ratios. Because of the existence of immature
 cells, thymomas can be thought of as functional tumors. Thymic
arcinomas are malignant epithelial tumors with overt cytologic
typia, and a lack of thymus-like features. This is one of the reasons
hy myasthenia gravis (MG) can accompany thymoma, but theo-
etically not thymic carcinoma. However, a retrospective analysis
f a Japanese database found that three of 304 patients with thymic
arcinomas (1%) had MG preoperatively [1]. Very few reports have
escribed MG associated with thymic carcinoma. The 5-year sur-
ival rates for all stages of thymoma and thymic carcinomas are
8% and 40%, respectively [2–4]. Although MG is very rarely asso-
iated with thymic carcinoma, this wide difference in survival rate
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cannot be ignored. Here, we  describe 2 cases of MG  associated with
thymic carcinoma.
2. Case presentations
2.1. Case 1
The patient was  a 54-year-old man. In 2005, he was  diagnosed
with MG  (Myasthenia Gravis Foundation of America (MGFA) IIA)
based on ﬁndings of eyelid ptosis, cervical muscle weakness, and
detection of anti-acetylcholine receptor antibody (ARAB). Com-
puted tomography (CT) revealed an anterior mediastinal tumor
30 mm in diameter. Treatment at that time comprised prednisolone
(PSL) and tacrolimus without surgery. Six years after diagnosis of
MG,  symptoms were improved and considered stable, and he was
therefore admitted to our hospital for surgical treatment of the thy-
moma.  Tumor diameter had grown from 30 mm to 40 mm (Fig. 1).
He underwent extended thymectomy and no postoperative com-
plications were seen. Pathological examination of frozen sections
showed type B2 thymoma. At 2 weeks after surgery, multiple liver
tumors were identiﬁed on CT. We  therefore performed liver tumor
biopsy and diagnosed small cell carcinoma. The ﬁnal histopatho-
roup Ltd. This is an open access article under the CC BY-NC-ND license (http://
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Fig. 1. Case 1. Computed tomography (CT) reveals an anterior mediastinal tumor,
40 mm in diameter.
Fig. 2. (a) Small-cell carcinoma with hematoxylin and eosin (HE) stain. (b) Immuno-
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Fig. 3. CT reveals an anterior mediastinal tumor 47 mm in diameter, invading the
superior vena cava.istochemistry with CD56 shows thymoma comprising 80% of the tumor and
mall-cell carcinoma comprising 20%.
ogical examination of the previously resected anterior mediastinal
umor revealed type B2-B3 thymoma (according to World Health
rganization (WHO) criteria) comprising 80% of the tumor, with
mall cell carcinoma making up the remaining 20%. Results for
euron-speciﬁc enolase (NSE), synaptophysin, and CD56 were pos-
tive in the small cell carcinoma and negative in the thymoma on
mmunohistochemistry (IHC) (Fig. 2)..2. Case 2
The patient was a 51-year-old woman. In 2004, she had been
iagnosed with MG (MGFA I) based on eyelid ptosis and detec-Fig. 4. Type B3 thymoma within squamous cell carcinoma.
tion of ARAB. Ten years after diagnosis of MG,  elevation of the
diaphragm was  detected on chest X-ray. CT revealed an anterior
mediastinal tumor 47 mm in diameter. We suspected tumor inva-
sion to the right phrenic nerve, right atrium, and superior vena cava
(Fig. 3), and preoperative radiotherapy (total 40 Gy) was therefore
selected. Although the tumor showed a reduction in diameter from
47 mm  to 37 mm,  invasion to the pericardium remained. At this
point, the decision was  made to perform surgery. Extended thymec-
tomy and partial resection of the right upper lobe (segments S2
and S3), right phrenic nerve, pericardium, and right pulmonary vein
(V2b and V3) were therefore performed. Pathological examination
revealed squamous cell carcinoma invading into the pericardium
and lung (Masaoka stage III), pT3N0M0 WHO  stage III. In this case,
the type B3 thymoma was slightly observed within the squamous
cell carcinoma (Fig. 4).
3. Discussion
The relationship between thymoma and MG  is well known. Gen-
erally, MG  has been considered most commonly associated with
WHO  type A, AB, or B thymoma, but theoretically should not be
associated with thymic carcinoma [5–9]. Most cases of thymic car-
cinoma appear to arise de novo, but a recent study found that
thymic carcinomas can arise in any histological type of thymoma,
and thymic carcinoma has been shown to develop in the necrotic
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issue of thymoma [10]. The point at which transformation to
hymic carcinoma occurs remains unclear. Kim et al. reported three
ases of thymic carcinoma with MG.  According to that report, all
uch cases involved type B2 or B3 thymoma in thymic carcinoma
11]. The interval between diagnosis and thymectomy was  10 days,
7 days, and 19 days in these three cases. Malignant transformation
f the tumor was considered to have occurred in the long period
efore tumor detection. Suster et al. reported two cases of thymic
quamous cell carcinoma that developed from thymoma after 10
nd 14 years [12]. We  therefore consider that MG  can accompany
hymic carcinoma during long-term observation of thymoma. In
ur two cases, surgery was performed after long-term follow-up of
0 and 6 years. In both cases, we were able to conﬁrm the pres-
nce of thymoma in thymic carcinoma. These ﬁndings were thus
onsistent with the reports from Suster et al. [12] and Kim et al.
11].
Since there is a possibility that thymic carcinoma is present in
G  thymoma, thymomic tissue with necrosis should be carefully
earched during pathological examinations. Even if MG  or ARAB
as been detected, the possibility of not only thymoma but also
hymic carcinoma cases should be considered for anterior medi-
stinal tumor under long-term observation.
. Conclusion
Thymic carcinoma can accompany MG.  Given the clear dif-
erence in 5-year survival rates between thymoma and thymic
arcinoma, we should keep in mind the possibility of thymic car-
inoma even in cases of MG,  especially in cases under long-term
bservation. Surgery for thymoma should be performed as soon as
ossible before transformation to carcinoma.
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